Company Cello Health plc

Equities

CLL

GB00B0310763

Delayed London S.E. Other stock markets			5-day change	1st Jan Change
- ^GBX	-.--%		-0.31%	+19.70%

2020	Value Demonstration UK Holdings Limited completed the acquisition of Cello Health plc.	CI
2020	Value Demonstration UK Holdings Limited reached an agreement to acquire Cello Health plc for approximately £170 million.	CI

Business Summary

Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.

Managers

Managers	Title	Age	Since
Rebecca Hyde COO	Chief Operating Officer	-	-
Mark Bentley BRD	Director/Board Member	54	-
Andrew Robert Brown SEC	Corporate Secretary	-	-

Members of the board

Members of the board	Title	Age	Since
Eugene Gorbach BRD	Director/Board Member	47	-
Mark Bentley BRD	Director/Board Member	54	-
Michael Bernstein BRD	Director/Board Member	64	-
Jon Williams BRD	Director/Board Member	49	-

Company contact information

Cello Health Ltd.

31 Old Nichol Street

E2 7HR, London

+44 20 7812 8460

https://cellohealthplc.com/

Group companies

Name	Category and Sector
CELLO HEALTH PLC	Miscellaneous Commercial Services

Sector

This company's sector is not yet available